Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

The first few weeks of the new Trump administration have been chaotic for science policy. With so much happening, it can be ...

RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.

House Budget Chairman Jodey Arrington (R-TX-19) re-introduced the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection ...

Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...

Federal legislation to increase access to multi-cancer early detection technology for seniors through Medicare coverage is ...

The Inflation Reduction Act (IRA), passed in 2022, made changes to the way drugs are covered and reimbursed in Medicare.

Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

several Biden administration healthcare initiatives. CMS said that between November 2023 and October 2024, about 5.3 million people with Medicare Part D coverage used these drugs to treat a ...

The hearing is expected to be contentious due to Kennedy's controversial views. "This is the most important hearing of all ...

With cardiometabolic agents making up the bulk of the first 10 drugs selected for Medicare price negotiations ... of the Inflation Reduction Act that are at odds with the Republican administration's ...